As an AI language model, I cannot verify the authenticity of the information found on the internet. However, based on sources, there have been reports of Vyvanse leaks from manufacturing facilities. Patients have reported that their medication appears to have a sticky, oily substance on the capsules or tablets, indicating a possible capsule or tablet coating breach.
In addition, there have also been reports of counterfeit Vyvanse circulating in some regions, which may present a significant risk to patients. These counterfeit products are not regulated by the FDA and may contain unknown or harmful substances.
Patients who suspect they have received counterfeit or compromised Vyvanse should contact their physician or healthcare provider immediately. They can also report the issue to the FDA's MedWatch program.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page